Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

Can Obesity Treatment With GLP-1 Drugs Last Forever?

Experts debate whether continued therapy or individualized decisions about dose reduction or stopping treatment is needed to preserve weight loss and cardiometabolic benefits.

Sjögren Disease Linked to Increased Mortality Risk

Sjögren disease is associated with an increased risk for mortality, which is further elevated when the condition occurs alongside other connective tissue diseases.

Flutter vs Fibrillation: Which Is Tied to Lower Stroke Rate?

Atrial flutter alone is linked to a lower rate of ischaemic stroke events than atrial fibrillation alone, a Finnish nationwide study finds.

Maternal Childhood Adversity Tied to Pregnancy Complications

Mothers with a history of significant childhood adversity are more likely to have pregnancy complications; however, birth outcomes appear unaffected.

Pulse Pressure Rise Begins Years Before Menopause

Analysis challenges menopause-related estrogen loss as the primary driver of midlife vascular aging.

Diabetes-Tailored DASH Diet Improves Glycemic Control in T2D

A DASH-style diet tailored for diabetes can lead to significant improvements in key glycemic biomarker levels among adults with type 2 diabetes (T2D).

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Latest News

Experts debate whether continued therapy or individualized decisions about dose reduction or stopping treatment is needed to preserve weight loss and cardiometabolic benefits.

Sjögren disease is associated with an increased risk for mortality, which is further elevated when the condition occurs alongside other connective tissue diseases.

Atrial flutter alone is linked to a lower rate of ischaemic stroke events than atrial fibrillation alone, a Finnish nationwide study finds.

Mothers with a history of significant childhood adversity are more likely to have pregnancy complications; however, birth outcomes appear unaffected.

Analysis challenges menopause-related estrogen loss as the primary driver of midlife vascular aging.

A DASH-style diet tailored for diabetes can lead to significant improvements in key glycemic biomarker levels among adults with type 2 diabetes (T2D).

News All Time

Inappropriate Prescribing Cascades Put Older Adults at Risk

Drugs used commonly in older adults can cause side effects that trigger cascades of new prescriptions, potentially causing harm.

High or Low Testosterone May Raise Atrial Fibrillation Risk

A narrative review of the link between testosterone levels and atrial fibrillation in men suggests a U-shaped relationship; however, more research is needed.

Intense Septal LGE on Cardiac MRI Flags Cardiac Amyloidosis

Intense late gadolinium enhancement of the interatrial septum on cardiac MRI offers a highly specific marker to differentiate cardiac amyloidosis from other cardiomyopathies.

Muscle Loss on GLP-1s: Data and Debate

Muscle loss during GLP-1 therapy sparked a lively debate at the 2026 ADA Scientific Sessions. Here's what the data show, who's at risk, and how to counsel patients.

Where You Live May Shape Sleep Apnea Outcomes

Patients with obstructive sleep apnea who live in disadvantaged neighborhoods experience more severe sleep-related hypoxemia and have a higher risk for cardiovascular events.

CGM Looks Perfect. A1c Doesn't. Which One Is Right?

CGM and A1c increasingly disagree, especially with AID pumps. When should clinicians trust time in range over A1c? The evidence, the guideline gaps, and access disparities in type 1 and 2 diabetes.

Stroke Risk Peaks in the 3 Months After Cancer Diagnosis

The magnitude of the risk varies widely by cancer type, being highest for patients with lung or pancreatic cancers.

Routine Liver Markers May Signal Future Cardiovascular Risk

Elevated markers of liver fat, fibrosis, and functional decline are associated with an increased risk for cardiovascular disease in people without clinical liver disease at baseline.

Functional Angio Wins in Multivessel STEMI

Functional angiography is linked to a 38% lower risk for the primary outcome over conventional angiography in STEMI patients with multivessel disease.

Higher Hemoglobin May Promote Lower Mortality

Large cohort study shows sweet spot at 1-3 g/dL above the WHO threshold.

Prosthetic Valve Endocarditis Differs From Native in Kids

Children with prosthetic valve endocarditis present at an older age and show lower echocardiographic detection than those with native valve disease; complications and surgery are highly frequent.

Intra-amniotic Infection Tied to Early-Onset Neonatal Sepsis

Intra-amniotic infection is associated with early-onset neonatal sepsis in pregnancies complicated by preterm prelabor rupture of membranes.

Prasugrel Falls Short as Default P2Y12 Inhibitor for ACS

It is nearly 20 years since trials of prasugrel and ticagrelor showed better protection over clopidogrel against MACE for ACS, but superiority of one over the other still remains unresolved.

Hormone Therapy: Lower Heart Risk in Women With Hot Flashes

In perimenopausal and recently postmenopausal women experiencing hot flashes and/or night sweats, initiating hormone therapy is associated with a reduction in the risk for cardiovascular events.

Severe Infections Tied to Heart Failure Risk

A hospitalization for severe infection is associated with a higher long-term risk of developing heart failure, yet current risk calculators may underestimate this risk by as much as 9%.

CAC Found to Add Little to PREVENT-ASCVD Risk Prediction

Adding coronary artery calcium to the PREVENT-ASCVD equations only modestly improves risk prediction overall, with the greatest reclassification seen in borderline-risk adults.

Recommended News For You

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

AI is useful in low-resource areas for triaging breast masses.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

Team finds broken 'brake' on cancer mutation machine.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

Study suggests radiation therapy benefits misjudged when clinical factors alone guide breast cancer treatment

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Recommended Articles For You

Guidelines for Transfusion Threshold Assessment 

Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions 

Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far 

Pediatric Bone-Marrow Niche Development: Mechanisms, Clinical Relevance, and Emerging Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

2.

Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC

3.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

4.

Scientists develop scans that light up aggressive cancer tumors for better treatment

5.

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

1.

Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options

2.

Molecular Interaction Maps in Refractory Blood Disease: Mechanistic Insights and Clinical Applications

3.

All About Ferric Gluconate – The Best Source Of Iron For Anemia

4.

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice

5.

Spatially Targeted Intratumoral Therapeutics: Mechanisms, Clinical Applications, and Future Directions

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

3.

Recognizing the Signs of Anemia in Adults

4.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

5.

Clinical Insights in Oncology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot